A recent study reported that one in six adult Americans—the equivalent of nearly 50 million people—currently takes an antidepressant. Many prescribing psychiatrists—and drug manufacturers—maintain that weaning off these medications entails mild and brief withdrawal symptoms. But Dr. Mark Horowitz, a psychiatrist and researcher who spent over a decade on antidepressants, says the reality can be far more dire. After trying to taper off his medication, Horowitz says he experienced debilitating withdrawal symptoms, worse than anything he had suffered during his earlier bouts of depression. He began to question the prevailing medical guidance on antidepressant withdrawal and the startling mismatch between what doctors were saying and what patients were actually experiencing. His research ultimately led the United Kingdom’s National Health Service to revise its guidelines on how to safely taper antidepressant medication. He also rejects some of the longstanding assumptions of modern psychiatry, specifically the idea that depression results from a chemical imbalance in the brain. According to Horowitz, the research has failed to establish a consistent genetic or neurobiological signature for depression. It is the circumstances of people’s lives—from relationships and financial pressures to trauma and social isolation—that most often explain their depressive feelings. What’s more, Horowitz says, clinical trials for antidepressants show only modest average improvements over placebos. Horowitz thinks addressing the underlying causes of a person’s distress is almost always more effective than attempting to alter their brain chemistry. Given his findings about antidepressants, I asked him about alternative interventions, including psychotherapy, exercise, ketamine, and psychedelics. We agreed to disagree on whether and how much psychedelics, particularly when combined with talk therapy, could help patients gain valuable, psychology-shifting insights into their lives that conventional treatments cannot. In the end, Horowitz cautioned against the potential harms of newer drug-based interventions. When the most significant driver of depression is psychosocial, as he believes it is, the most effective remedy isn’t what he describes as the emotional numbing of an antidepressant or the mind-altering experience of psychedelic drugs, but a real reckoning with the root causes of unhappiness in our lives. From Psychiatrist to Patient: How Marc Horowitz Got Here “Welcome to another episode of Conversations with Coleman.” What It Was Like to Come Off Lexapro “Yeah, please. Please do. What was it like trying to wean off of SSRI?” Why Official Side Effect Data Misses What Patients Report “Yeah. So a lot of different places I could go from there.” Benzodiazepines, Antidepressants and the Jordan Peterson Case “Yeah, I mean, I think a lot of people have been getting an education about benzodiazepine withdrawal...” Why Tolerance and Withdrawal Are Two Sides of the Same Coin “So you mentioned earlier that there is a conceptual connection...” Why Antidepressants Take Six Weeks to Work “Why is it commonly, my layperson’s understanding is that whenever someone gets prescribed SSRI...” How Big Is the Gap Between Antidepressants and Placebo? “Okay. So when you say there is a ten point improvement for placebo...” Is Depression a Chemical Imbalance? “Yeah, that’s actually exactly where I was going to go next.” Is the Cause in the Brain or in Life Events? “Okay. So let’s, okay, forget serotonin.” Can Depression Come Out of Nowhere? “That’s interesting. So like at some level, we’re talking about levels of explanation.” Where Does Normal Sadness End and Illness Begin? “Okay, so I can imagine two separate conversations.” The Lindsay Clancy Case and Medication Changes “Did you follow the Lindsey Clancy case at all?” Are Ketamine, MDMA and Psychedelics the Answer? “It seems like one of the upshots of your critique on how we think about depression...” Advice for Anyone Struggling With Depression Right Now “Okay. Marc Horowitz, I’m out of questions for now.”